Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.
about
Relevance of human metapneumovirus in exacerbations of COPDHuman Metapneumovirus: lessons learned over the first decadeDendritic cells in human Pneumovirus and Metapneumovirus infectionsPhylogenetic and phylodynamic analyses of human metapneumovirus in Buenos Aires (Argentina) for a three-year period (2009-2011)Solution and Crystallographic Structures of the Central Region of the Phosphoprotein from Human MetapneumovirusStructure and Self-Assembly of the Calcium Binding Matrix Protein of Human MetapneumovirusDrastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in PneumovirinaeHuman metapneumovirus in adultsEmerging infectious diseases: vulnerabilities, contributing factors and approachesHuman Metapneumovirus Is Capable of Entering Cells by Fusion with Endosomal MembranesThe clinical presentation and outcomes of children infected with newly identified respiratory tract virusesRhinovirus frequently detected in elderly adults attending an emergency department.Molecular diagnosis of respiratory virus infections.The role of infections and coinfections with newly identified and emerging respiratory viruses in children.Epidemiological analysis of respiratory viral etiology for influenza-like illness during 2010 in Zhuhai, China.Distribution of influenza and other acute respiratory viruses during the first year after the 2009-2010 influenza pandemic in the English- and Dutch-speaking Caribbean countriesHuman metapneumovirus infections in childrenA recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.Human metapneumovirus infections in adults: another piece of the puzzle.Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virusDetection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody testSubversion of pulmonary dendritic cell function by paramyxovirus infectionsPopulation-based incidence of human metapneumovirus infection among hospitalized children.Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.Human metapneumovirus infections are associated with severe morbidity in hospitalized children of all agesThe cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.Soluble recombinant human metapneumovirus G protein is immunogenic but not protective.Studies of culture conditions and environmental stability of human metapneumovirus.Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus.Small hydrophobic protein of human metapneumovirus does not affect virus replication and host gene expression in vitroHuman Metapneumovirus: An Important Cause of Respiratory Disease in Children and Adults.Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.Genetic variability of attachment (G) and Fusion (F) protein genes of human metapneumovirus strains circulating during 2006-2009 in Kolkata, Eastern IndiaAssociation of human metapneumovirus with acute otitis mediaHuman metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults.A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections.Impact and regulation of lambda interferon response in human metapneumovirus infectionThe role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience.Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract.Identification of new respiratory viruses in the new millennium.
P2860
Q25257128-47A271CD-BF29-4220-A253-1539C62AF4EBQ26822938-1792630B-9E86-4FC7-BC40-E8F074623DC5Q26865337-0DE79587-946C-4BB9-81B8-B61C5CD5BC9EQ27321317-4B56C308-A8E4-408F-AAAF-2F7BEA809BB0Q27680597-563FCB5F-4212-4A2E-B164-8F147DE77A23Q27680813-5257ED1F-73EB-4F2B-AB00-0F05F190C260Q27683836-7B1B2BAF-2DAC-4595-AE7C-B3BFD0333CF6Q27694039-C24A8D8D-08D2-4B0D-B092-0185D92D2BA7Q28287659-513FA6F6-8860-463D-A23F-1C2BDEBA11B8Q28551244-E6E7C551-88F1-45F0-9E8B-640B1A487974Q30351241-EBBEAA36-B03A-4801-A9DA-ADDACA0506EFQ30407055-7EF1B01B-C0AF-4020-AF08-124963BA4565Q30410887-8BA4D9B2-4F25-4116-8460-A72DABB255A7Q30422891-103EB0C3-72A9-415C-A2D6-268E668AD5E7Q30430230-195E7B38-0373-4E0E-BA24-EDB04B30A32FQ30431592-D6D12B64-FF67-49A8-AF4F-4345AB918CD0Q30491765-CA0D9721-B533-498A-9C1B-BA7E1142942AQ33285591-A93AE40C-40C8-4615-8A38-31C1EF66AFE6Q33346409-D048269A-ABB0-4F8A-B78A-CA68363F4253Q33752841-7852C209-F744-4076-A484-A9952220DC23Q33753055-D6F86A26-A819-47A9-9F12-E40171E40ADAQ33832308-78BC0833-F4A5-4EFB-82CD-6FC15F2AC04BQ33862733-456B93C3-4549-4FB5-8656-E22E524D1DABQ33911955-112B20BE-91B5-49F2-BF0F-494C6C526080Q33930122-122BC934-0410-46F2-B81A-D33DBC009822Q33930308-D6F9646D-4E58-4781-A37D-EC998F7C3159Q33950358-8F232A88-D846-4843-90F8-0A2C4E0D955FQ33950385-8D367ED2-16EF-468C-A20F-20B3D2A908EDQ34142925-4C45A794-9A0C-454F-8995-5C96D06444F2Q34332549-35CCCD33-5C7B-4477-BEF3-F35925BAEB8EQ34557032-4B992064-929C-48BE-A517-699A9B2AF36EQ34569141-4D493574-2A4A-465A-9109-A157B1880973Q34610838-DF09CEBE-D849-4256-8EAD-BC00948BA8FEQ34669696-01EE4F3F-E75E-46E5-8B31-BE7BE75FAEC3Q34669860-60E2A509-4488-4A39-9CCF-2A3286930BB4Q34698361-8650CC89-A3BF-4DA2-80F4-2C3D1EAA6429Q34992701-BC22DC68-D0A1-4D71-8229-31EAC582042DQ35062456-A658191C-3CAE-4B9F-B461-85B0473618F7Q35098358-1131D243-82C6-4EF6-9696-B619AE0DE515Q35232791-61772D9D-527C-4679-AA09-F87229A99033
P2860
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prevalence and clinical sympto ...... tion in hospitalized patients.
@en
Prevalence and clinical sympto ...... tion in hospitalized patients.
@nl
type
label
Prevalence and clinical sympto ...... tion in hospitalized patients.
@en
Prevalence and clinical sympto ...... tion in hospitalized patients.
@nl
prefLabel
Prevalence and clinical sympto ...... tion in hospitalized patients.
@en
Prevalence and clinical sympto ...... tion in hospitalized patients.
@nl
P2093
P356
P1476
Prevalence and clinical sympto ...... tion in hospitalized patients.
@en
P2093
Bernadette G van den Hoogen
Gerard J J van Doornum
Jan J Cornelissen
John C Fockens
Ronald de Groot
Walter E P Beyer
P304
P356
10.1086/379200
P407
P577
2003-10-27T00:00:00Z